The Clinical Inadequacy of the Placebo Model and the Development of an Alternative Conceptual Framework
Fava GA, Guidi J, Rafanelli C, Rickels K.
Psychother Psychosom. 2017;86(6):332-340.
Withdrawal Symptoms after Serotonin-Noradrenaline Reuptake Inhibitor Discontinuation: Systematic Review
Fava GA, Benasi G, Lucente M, Offidani E, Cosci F, Guidi J.
Psychother Psychosom. 2018;87(4):195-203.
Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review
Fava GA, Gatti A, Belaise C, Guidi J, Offidani E.
Psychother Psychosom. 2015;84(2):72-81.
Iatrogenic Factors in Psychopathology
Fava GA, Rafanelli C.
Psychother Psychosom. 2019;88(3):129-140. doi: 10.1159/000500151. Epub 2019 May 14.
Addressing Clinical Challenges of Antidepressant Discontinuation
Fava GA, Cosci F.
Am J Psychiatry. 2019;176(6):487-488
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs
Fava GA, Cosci F.
J Clin Psychiatry. 2019;80(6)
Discontinuing Antidepressant Drugs: Lesson from a Failed Trial and Extensive Clinical Experience
Fava GA, Belaise C.
Psychother Psychosom. 2018;87(5):257-267.
The Safety, Tolerability and Risks Associated with the Use of Newer Generation Antidepressant Drugs: A Critical Review of the Literature
Carvalho AF, Sharma MS, Brunoni AR, Vieta E, Fava GA.
Psychother Psychosom. 2016;85(5):270-88.
Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis
Offidani E, Guidi J, Tomba E, Fava GA
Psychother Psychosom. 2013;82(6):355-62.
Benzodiazepines as a Monotherapy in Depressive Disorders: A Systematic Review
Benasi G, Guidi J, Offidani E, Balon R, Rickels K, Fava GA.
Psychother Psychosom. 2018;87(2):65-74.
International Task Force on Benzodiazepines
Balon R, Chouinard G, Cosci F, Dubovsky SL, Fava GA, Freire RC, Greenblatt DJ, Krystal JH, Nardi AE, Rickels K, Roth T, Salzman C, Shader R, Silberman EK, Sonino N, Starcevic V, Weintraub SJ.
Psychother Psychosom. 2018;87(4):193-194.
What psychologists need to know about psychotropic medications
Tomba E, Guidi J, Fava GA.
Clin Psychol Psychother. 2018;25(2):181-187.
Benzodiazepines can help depression
A recent paper published in Psychotherapy and Psychosomatics by Dr. Fava points to the important role that benzodiazepines may have in managing anxious and mild depression and present many advantages over antidepressants.
Read More »Antidepressants and Withdrawal
In a widely read article on antidepressant withdrawal, which refers to Dr. Fava’s work, The New York Times invited readers to describe their experiences coming off the drugs. More than 8,800 people responded — teenagers, college students, new mothers, empty-nesters, retirees. Read the article here.
Read More »The psychological impact of medications
Clinical pharmacopsychology consists of the application of clinical psychology to the full understanding of
pharmacological effects. Clinical pharmacopsychology encompasses clinical benefits of psychotropic drugs as well as vulnerabilities induced by treatment (side effects, behavioral toxicity, iatrogenic comorbidity) and the interactions between drug treatment and psychological variables such as quality of life and psychological well-being. To know more about clinical pharmacopsychology read the full article on Psychotherapy and Psychosomatic.
What prescribers and patients do not know of the side effects of antidepressants
Newer generation antidepressant drugs are widely used as the first line of treatment for major depressive disorders and are considered to be safer than tricyclic agents. In the current issue of Psychotherapy and Psychosomatics an international group of investigators outlines the side effects that long-term treatment with antidepressant drugs may induce. Their analysis showed that several side effects are transient and may disappear after a few weeks following treatment initiation, but potentially serious adverse events may persist or ensue later. The senior Author of the paper, Giovanni A. Fava, M.D., commented: “It is very unlikely that most of the prescribers of antidepressant drugs are aware of these side effects, because of a tight censorship that has been in action all these years.”
Read More »